BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 8429253)

  • 1. [Pharmacokinetics of CDDP by the route of administration in patients with ovarian cancer].
    Takada M; Usui N; Suzuki M; Furugen Y; Yamamoto T
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 Feb; 45(2):99-105. PubMed ID: 8429253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraperitoneal high-dose cisplatinum chemotherapy (CDDP-ip) in patients with carcinomatous peritonitis].
    Noda T; Oku M; Kiyozuka Y; Ninomiya Y; Hino K; Okamura Y; Maruyama M; Ichijo M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1025-32. PubMed ID: 3566301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intraperitoneal chemotherapy of CDDP and etoposide in patients with advanced ovarian cancer].
    Hirashima Y; Shimura T; Tanaka Y; Demukai H; Kubota T; Kobayashi T; Suzuki A
    Gan To Kagaku Ryoho; 1993 Aug; 20(10):1321-6. PubMed ID: 8346930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic analysis of intra-peritoneal administration of cisplatin].
    Terashima M; Ikeda K; Takagane A; Sasaki N; Abe K; Araya M; Nishizuka S; Yonezawa H; Irinoda T; Nakaya T; Oyama K; Saito K
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1859-62. PubMed ID: 9382551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics following intraperitoneal infusion of cisplatinum with and without sodium thiosulfate rescue in carcinomatous peritonitis in advanced gastric cancers].
    Namatame K; Kou Y; Nakayoshi A
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1784-9. PubMed ID: 1877818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in intraperitoneal intraoperative cisplatin exposure based on pharmacokinetic analysis in patients with ovarian cancer.
    Royer B; Delroeux D; Guardiola E; Combe M; Hoizey G; Montange D; Kantelip JP; Chauffert B; Heyd B; Pivot X
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):415-21. PubMed ID: 17503047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The pharmacokinetics of intraperitoneal (IP) carboplatin (CBDCA) and dose-up study of intravenous (IV) cyclophosphamide (CPM) in combination with IP CBCDA for advanced ovarian cancer patients].
    Fujiwara K; Yamauchi H; Sawada S; Koike H; Mohri H; Ohishi Y; Kohno I
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2373-9. PubMed ID: 1463344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of recombinant human interleukin 3 administered subcutaneously and by continuous intravenous infusion in patients after chemotherapy for ovarian cancer.
    Biesma B; Pokorny R; Kovarik JM; Duffy FA; Willemse PH; Mulder NH; de Vries EG
    Cancer Res; 1993 Dec; 53(24):5915-9. PubMed ID: 8261403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood flow pattern and tumor vascular change following intraperitoneal administration of CDDP in VX2 ovarian tumor].
    Hasegawa E
    Nihon Sanka Fujinka Gakkai Zasshi; 1993 May; 45(5):451-6. PubMed ID: 8496635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacokinetics following intraperitoneal sequential administration of cisplatin and fluorouracil for gastric cancer].
    Hiratsuka M; Furukawa H; Iwanaga T; Nakamori S; Masutani S; Ohigashi H; Kameyama M; Sasaki Y; Kabuto T; Ishikawa O
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1627-30. PubMed ID: 8373234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and clinical evaluation of cisplatin-containing microspheres as intraperitoneal chemotherapy for ovarian cancer.
    Sugiyama T; Kumagai S; Nishida T; Ushijima K; Matsuo T; Yakushiji M; Hyon SH; Ikada Y
    Anticancer Res; 1998; 18(4B):2837-42. PubMed ID: 9713471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetics of carboplatin after intraperitoneal administration and clinical effect in ovarian cancer].
    Ohno M; Hirokawa M; Hando T
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2355-61. PubMed ID: 1463342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CDDP-ip PMUE therapy in gastric cancer cases with liver metastasis].
    Hasegawa Y; Honnma S; Takanashi K; Yajima K; Nakashima Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):2047-51. PubMed ID: 1908669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy in malignant gynecologic tumors using intraperitoneal catheter with a subcutaneous reservoir].
    Shimizu A; Kimura T; Funatsu M; Hada Y; Araki H; Notake Y
    Gan To Kagaku Ryoho; 1991 Aug; 18(11):1795-9. PubMed ID: 1877820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intraperitoneal chemotherapy using CBDCA for malignant gynecological tumors].
    Shimizu A; Kimura T; Funatsu M; Hada Y; Tamura K; Taguchi A; Miyakawa Z; Notake Y
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1738-41. PubMed ID: 1530345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetics study of intraperitoneal cisplatin in ovarian carcinoma].
    Han GR; Cai GF
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):224-6, 254. PubMed ID: 8404307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The clinical and pharmacokinetic evaluation of two-route chemotherapy with cisplatin and sodium thiosulfate in combination with angiotensin II].
    Takizawa K; Harada M; Fujimaru J; Matsushiro N; Shima Y; Andoh I; Satoh M; Yokoo I; Iguchi T; Hirabayashi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 May; 44(5):595-602. PubMed ID: 1619320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
    Gray HJ; Shah CA; Swensen RE; Tamimi HK; Goff BA
    Gynecol Oncol; 2010 Mar; 116(3):340-4. PubMed ID: 19922987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cis-diamminedichloroplatinum penetration into the cerebrospinal fluid of the lateral ventricle, postoperative cavity, and lumbar subarachnoid space with or without pre-intravenous mannitol administration in patients with brain metastasis from lung cancer].
    Nakagawa H; Yamada M; Tamura M; Yoshida M; Shindo M; Nishiyama H; Sakai S
    Gan To Kagaku Ryoho; 2014 Mar; 41(3):317-24. PubMed ID: 24743276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.